PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Pantaflix AG (PAL.DE)
1.170.03 (-2.50%)
1.14 - 1.17
1.10 - 1.60
14.0K / 2.1K (Avg.)
-9.00 | -0.13
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-56.46%
Negative revenue growth while PGN.DE stands at 6.77%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-119.46%
Negative gross profit growth while PGN.DE is at 15.89%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1378.72%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1378.76%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-3782.79%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4039.39%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-4039.39%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-8.36%
Share reduction while PGN.DE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-8.33%
Reduced diluted shares while PGN.DE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
17.79%
Positive OCF growth while PGN.DE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
17.75%
Positive FCF growth while PGN.DE is negative. John Neff would see a strong competitive edge in net cash generation.
31.37%
10Y revenue/share CAGR under 50% of PGN.DE's 111.94%. Michael Burry would suspect a lasting competitive disadvantage.
-53.15%
Negative 5Y CAGR while PGN.DE stands at 53.14%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-55.05%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
20.11%
5Y OCF/share CAGR above 1.5x PGN.DE's 10.03%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
421.06%
3Y OCF/share CAGR above 1.5x PGN.DE's 122.58%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-205.60%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
3.70%
Positive 5Y CAGR while PGN.DE is negative. John Neff might view this as a strong mid-term relative advantage.
67.24%
3Y net income/share CAGR 75-90% of PGN.DE's 77.52%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
-35.79%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-65.92%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.85%
Firm’s AR is declining while PGN.DE shows 6.83%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-29.33%
Inventory is declining while PGN.DE stands at 11.55%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
42.58%
Asset growth above 1.5x PGN.DE's 1.46%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-25.14%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
122.78%
We have some new debt while PGN.DE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-38.97%
We cut SG&A while PGN.DE invests at 63.96%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.